VELCERA, LLC – Trademark Portfolio

Entity Type: 16

VELCERA, LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 12 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include PETARMOR and YOU ARE YOUR PET'S ARMOR. The owner is based in EAGLE, ID.

230 E. Riverside Drive

EAGLE, ID 83616

13 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

VELCERA, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (12 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does VELCERA, LLC have?

VELCERA, LLC has 13 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 6 abandoned, 2 cancelled.

What trademark classes does VELCERA, LLC file in?

VELCERA, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are VELCERA, LLC's most well-known trademarks?

VELCERA, LLC's registered trademark portfolio includes well-known marks such as PETARMOR and YOU ARE YOUR PET'S ARMOR. These are among 3 currently registered trademarks in the portfolio.

What is VELCERA, LLC's trademark registration success rate?

VELCERA, LLC has a 27% trademark registration rate, with 3 out of 11 resolved applications resulting in successful registration. Currently, 2 applications are pending review.